BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• BioCapital

  Cerecor Inc. To Present At The 15th Annual BIO Investor Forum In San Francisco On October 18th, 2016

  October 10, 2016

   · 

  1 min read
• Drug Development

  Dynavax Presents Early Clinical Data From Lead Cancer Immunotherapy Candidate, SD-101, At ESMO Annual Congress

  October 10, 2016

   · 

  3 min read
• Business

  Alexion To Report Third Quarter 2016 Results On Thursday, October 27, 2016

  October 10, 2016

   · 

  1 min read
• Drug Development

  Viralytics Ltd Updates CAVATAK and KEYTRUDA Combination Clinical Trials At ESMO 2016

  October 10, 2016

   · 

  4 min read
• BioMidwest

  Sensient Tech Announces Conference Call

  October 10, 2016

   · 

  1 min read
• BioCapital

  Cerecor Inc. To Present At The 15th Annual BIO Investor Forum In San Francisco On October 18th, 2016

  October 10, 2016

   · 

  1 min read
• Drug Development

  Viralytics Ltd Release: CAVATAK YERVOY Combination Demonstrates Promising Clinical Response Rates In Advanced Melanoma

  October 10, 2016

   · 

  8 min read
• FDA

  Clever Culture Systems AG Release: U.S. FDA Grants Approval For LBT’s APAS

  October 10, 2016

   · 

  2 min read
• Helsinn Investment Fund Invests £2.0 Million In QuantuMDx

  October 10, 2016

   · 

  5 min read
• Almac Group Discover An Exciting Link Between Its Immune Response Assay And Checkpoint Inhibitor Based Therapy

  October 10, 2016

   · 

  2 min read